Abstract
A focused series of octapeptides based on the lead compound H-His-Ala-Lys-Arg-Arg-Leu-Ile-Phe-NH(2) 1, in which the C-terminal phenylalanine residue was replaced by alpha and/or beta-modified variants, was synthesized using solid-phase chemistry. Both the L-threo-beta-hydroxy-phenylalanine (beta-phenylserine, Pse) and (2S)-phenylalaninol derivatives, as competitive binders at the cyclin-recruitment site, displayed potent inhibitory activity towards the CDK2-cyclin A complex. Unexpectedly, the D-threo-Pse derivatives also showed inhibitory activity.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amino Acid Sequence
-
CDC2-CDC28 Kinases*
-
Chromatography, High Pressure Liquid
-
Cyclin A / antagonists & inhibitors*
-
Cyclin A / chemistry
-
Cyclin-Dependent Kinase 2
-
Cyclin-Dependent Kinases / antagonists & inhibitors*
-
Cyclin-Dependent Kinases / chemistry
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology*
-
Models, Molecular
-
Peptides / chemistry
-
Peptides / pharmacology*
-
Protein Serine-Threonine Kinases / antagonists & inhibitors*
-
Protein Serine-Threonine Kinases / chemistry
Substances
-
Cyclin A
-
Enzyme Inhibitors
-
Peptides
-
Protein Serine-Threonine Kinases
-
CDC2-CDC28 Kinases
-
Cyclin-Dependent Kinase 2
-
Cyclin-Dependent Kinases